Back to Agenda
SESSION 21:REGULATORY COMPLIANCE AND FDA INSPECTIONS: WHAT TO EXPECT AFTER SUBMITTING THE NDA
Session Chair(s)
Michael Hamrell, PHD, RAC
President
MORIAH Consultants, United States
Speaker(s)
REGULATORY COMPLIANCE AND FDA INSPECTIONS: WHAT TO EXPECT AFTER SUBMITTING THE NDA
Carol H. Danielson, DrPH, MS, RAC
Regulatory Advantage, LLC, United States
President
Have an account?